ELIQUIS 5 MG Ísrael - enska - Ministry of Health

eliquis 5 mg

pfizer pharmaceuticals israel ltd - apixaban - film coated tablets - apixaban 5 mg - apixaban - apixaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ≥ ii).treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) in adults.

Lipertance tablets film-coated Armenía - enska - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

lipertance tablets film-coated

les laboratoires servier industrie 905 - atorvastatin (atorvastatin calcium trihydrate), perindopril arginine, amlodipine (amlodipine besilate) - tablets film-coated - 20mg+ 10mg+ 5mg

IBOO 2 % FOR CHILDREN Ísrael - enska - Ministry of Health

iboo 2 % for children

abic marketing ltd, israel - ibuprofen - suspension - ibuprofen 100 mg / 5 ml - ibuprofen - for the reduction of fever and relief of mild to moderate pain.

VYVANSE 50 MG Ísrael - enska - Ministry of Health

vyvanse 50 mg

medison pharma ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 50 mg - lisdexamfetamine - vyvanse is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above.vyvanse is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years.limitation of use:vyvanse is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of vyvanse for the treatment of obesity have not been established

ELIQUIS 2.5 MG Ísrael - enska - Ministry of Health

eliquis 2.5 mg

pfizer pharmaceuticals israel ltd - apixaban - film coated tablets - apixaban 2.5 mg - apixaban - apixaban - prevention of venous thromboembolic events (vte) in adult patients who have undergone elective hip or knee replacement surgery.prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ≥ ii).treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.